Kalin Katherine Bach (CIK 1832671) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-09). Recent activity: Buy SLS (50,000 shares), Buy SLS (63,400 shares), Buy SLS (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-09 | SELLAS Life Sciences Group, Inc. (SLS) | Director | Buy | 50,000 | $0 |
| 2025-11-21 | SELLAS Life Sciences Group, Inc. (SLS) | Director | Buy | 63,400 | $100,806 |
| 2025-05-22 | SELLAS Life Sciences Group, Inc. (SLS) | Director | Buy | 20,000 | $36,000 |
来源：SEC Form 4 申报文件 · 截至 2026-01-09